Related Experiment Video
Updated: Jan 28, 2026

Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
Iron Status and Metabolically Unhealthy Obesity in Prepubertal Children
Milton Fabian Suárez-Ortegón1,2, Isabella Echeverri3, Anna Prats-Puig4,5,6
1Basic and Clinic Sciences Group-Department of Basic Sciences of Health, Pontificia Universidad Javeriana, Cali, Colombia.
Insights
Metabolically unhealthy obesity (MUO) in children is linked to higher iron markers like ferritin and hemoglobin. This suggests potential liver involvement in iron dysregulation in obese youth.
Area of Science:
- Pediatric Endocrinology
- Nutritional Science
- Metabolic Health
Background:
- Obesity in children is a growing concern with varying metabolic profiles.
- Understanding the link between obesity phenotypes and micronutrient status is crucial for pediatric health.
- Iron status is a key indicator of overall health and metabolic function.
Purpose of the Study:
- To investigate the association between metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUO) and iron status markers.
- To analyze iron status markers (ferritin, transferrin, hemoglobin) in prepubertal children with overweight and obesity.
- To differentiate iron status between metabolically healthy and unhealthy obesity phenotypes.
Main Methods:
- Evaluated 312 prepubertal children with overweight/obesity from a Spanish population.
- Defined MHO and MUO based on the presence or absence of metabolic syndrome components.
- Measured serum ferritin, transferrin, and hemoglobin levels.
Main Results:
- Prevalence of MHOV (metabolically healthy overweight including obesity) was 35%.
- Children with MUOV (metabolically unhealthy overweight including obesity) showed higher ferritin and hemoglobin levels compared to MHOV.
- MUO was significantly associated with increased ferritin and hemoglobin, independent of several covariates.
Conclusions:
- Metabolically unhealthy obesity (MUO) in prepubertal children is associated with elevated ferritin and hemoglobin levels.
- The increased ferritin in MUO may be influenced by underlying liver injury.
- These findings highlight the importance of assessing iron status in the context of metabolic health in obese children.
Objective:
This study aimed to evaluate the association of metabolically healthy obesity (MHO) and metabolically unhealthy obesity (MUO) with iron status markers in prepubertal children.
Methods:
Three hundred twelve prepubertal children with overweight and obesity from a pediatric general Spanish population were evaluated. MHO and MUO were defined as obesity with the absence or presence of metabolic syndrome components. Phenotypes of metabolically healthy overweight including obesity (MHOV) and metabolically unhealthy overweight including obesity (MUOV) were also studied and defined using the same criteria. Serum ferritin, transferrin, and blood hemoglobin levels were evaluated.
Results:
Prevalence rates of MHOV and MHO were 35% (n = 111/312) and 27.1% (n = 42/155), respectively. Ferritin and hemoglobin levels were higher in children with MUOV versus MHOV (P < 0.05). MUO was positively associated with ferritin (beta [95% CI] = 0.43 [0.05 to 0.81]) and hemoglobin levels (0.43 [0.05 to 0.81]). These associations remained significant independently of age, sex, C-reactive protein, physical activity, and BMI/waist z scores in bivariate linear regression models. In multivariable models, transaminase levels attenuated the association of MUO with ferritin and hemoglobin levels (P > 0.05).
Conclusions:
MUOV and MUO are associated with higher ferritin and hemoglobin levels in prepubertal children affected by overweight and obesity. Increased circulating ferritin in MUO might be influenced by liver injury.
More Related Videos
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
08:45Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
Published on: May 10, 2022
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Obesity
What is Metabolism?
Marcia's Theory of Identity Status
Drug Dosing: Obese Patients
Drug Dosing: Infants and Children